These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10293367)

  • 1. The effect of patient charges on the utilisation of prescription medicines.
    O'Brien B
    J Health Econ; 1989 Mar; 8(1):109-32. PubMed ID: 10293367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charging for health care: evidence on the utilisation of NHS prescribed drugs.
    Ryan M; Birch S
    Soc Sci Med; 1991; 33(6):681-7. PubMed ID: 1957188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient charges and the utilisation of NHS prescription medicines: some estimates using a cointegration procedure.
    Hughes D; McGuire A
    Health Econ; 1995; 4(3):213-20. PubMed ID: 7550771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between increasing prescription charges and consumption in groups not exempt from charges.
    Birch S
    J R Coll Gen Pract; 1986 Apr; 36(285):154-6. PubMed ID: 3735198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Media and medical response to the introduction of prescription charging in the National Health Service.
    Koizia L; Zielicka Z
    Pharm Hist (Lond); 2009 Dec; 39(4):59-64. PubMed ID: 20509505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design.
    Baker A; Chen LC; Elliott RA; Godman B
    BMC Health Serv Res; 2015 Sep; 15():367. PubMed ID: 26359265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?
    Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):550-555. PubMed ID: 29047196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of the cost and utilisation of pharmaceuticals in the United Kingdom.
    Burstall ML
    Health Policy; 1997 Sep; 41 Suppl():S27-43. PubMed ID: 10174472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prescription charges in a health maintenance organization.
    Karls TA; Peterson CR; Thielke TS
    Am J Hosp Pharm; 1989 Aug; 46(8):1562-6. PubMed ID: 2773960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are prescribed and over-the-counter medicines economic substitutes? A study of the effects of health insurance on medicine choices by the elderly.
    Stuart B; Grana J
    Med Care; 1995 May; 33(5):487-501. PubMed ID: 7739273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of H2-receptor antagonists.
    Andrade SE; Gurwitz JH; Fish LS
    Med Care; 1999 Apr; 37(4):424-30. PubMed ID: 10213023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to medicines: cost as an influence on the views and behaviour of patients.
    Schafheutle EI; Hassell K; Noyce PR; Weiss MC
    Health Soc Care Community; 2002 May; 10(3):187-95. PubMed ID: 12121255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UK interventions to control medicines wastage: a critical review.
    White KG
    Int J Pharm Pract; 2010 Jun; 18(3):131-40. PubMed ID: 20509346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of increasing the re-supply interval on the seasonality of subsidised prescription use in Australia.
    Donnelly N; McManus P; Dudley J; Hall W
    Aust N Z J Public Health; 2000 Dec; 24(6):603-6. PubMed ID: 11215008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHS charges. Light on the charge brigade.
    Eversley J; Webster C
    Health Serv J; 1997 Jul; 107(5562):26-8. PubMed ID: 10169049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Information systems for the analysis of drug prescriptions in Spain.
    Ferrando MC
    Ann Ist Super Sanita; 1991; 27(2):213-6. PubMed ID: 1755573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring prescribing: the shortcomings of the item.
    Bogle SM; Harris CM
    BMJ; 1994 Mar; 308(6929):637-40. PubMed ID: 8148715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charge ahead.
    Moore A
    Nurs Stand; 2005 Apr 20-26; 19(32):26-7. PubMed ID: 15875580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of drug treatment in the NHS.
    Keable-Elliott RA
    Br Med J; 1979 Sep; 2(6192):749-50. PubMed ID: 509106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.